All Updates

All Updates

icon
Filter
Funding
Onego Bio raises USD 40 million in Series A funding to boost manufacturing and commercialization
Plant-based Dairy & Egg
Apr 2, 2024
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Apr 2, 2024

Onego Bio raises USD 40 million in Series A funding to boost manufacturing and commercialization

Funding

  • Onego Bio, a Finnish plant-based egg producer, has raised USD 40 million in Series A funding led by NordicNinja, with participation from Tesi, EIT Food, Agronomics, Maki.vc, and Holdix and Turret, among others. This round also included USD 10 million in non-dilutive funding from Business Finland.

  • The new funding will be used to support its North American commercialization efforts, including scaling production capacity and increasing the headcount of the US commercial team. Further, the company will partner with co-manufacturers to expedite its market entry process.

  • Analyst QuickTake: Onego Bio uses a combination of precision fermentation and cellular agriculture to develop Bioalbumen (animal-free egg protein). The company is on track to commercialize Bioalbumen in the US with self-affirmed GRAS status and a "no objections letter" from the FDA expected soon.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.